In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Turing Pharmaceuticals AG

www.turingpharma.com

Latest From Turing Pharmaceuticals AG

Drug Pricing Hearing Takes A Partisan Turn As Gilead’s O’Day Holds His Own

Republicans took off the gloves at House oversight hearing on PrEP, arguing Democrats are more interested in scoring political points than seeking policy solutions to high drug costs.
Pricing Debate Legislation

The Return Of The “Specialty” Drug Pricing Debate In The US

Pharma has been almost wholly successful in shifting the ground in the US drug pricing debate away from high-cost “specialty” products and towards the large gap between list and net prices, with the most intense focus on older medicines like insulin. What happens when the debate shifts back?
Pricing Debate Reimbursement

Pharma Tweeting: Five Twitter Moments That Highlight The Perils Of The Platform

Scrip takes a broad look at some controversial Twitter moments that pharma should be watchful of  - words once let out of the cage cannot be whistled back again.

Leadership Strategy

Drug Pricing And The Trump Effect: How To Make A High Profile Hearing Vanish

Without President Trump’s focus on drug pricing, it is hard to imagine that seven top industry executives would have had to face a grilling in the US Senate Finance Committee. But they can also thank Trump’s indiscretions for helping ensure that the hearing was barely even a one-day story.

 

Pricing Debate Reimbursement
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • Turing Pharmaceuticals LLC
  • Turing Pharmaceuticals LLC
  • Turing Pharmaceuticals LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Turing Pharmaceuticals AG
  • Senior Management
  • Ron Tilles, Interim CEO
    Nancy Retzlaff, Chief Commercial Officer
    Eliseo Oreste Salinas, MD, Pres., R&D
  • Contact Info
  • Turing Pharmaceuticals AG
    Phone: 41 760 24 24
    Haldenstrasse 5
    Baar, NY CH-6340
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register